Becoming a member of CBH brings many benefits to your agency, including access to a large advocacy network of behavioral health care providers, opportunities to apply for ground-breaking new practice improvement initiatives, access to leading experts in the field of addiction and mental health, and so much more. CBH’s annual events include: ?
The 2019 CBH Annual Meeting and conference was May 16th at the Mt. Washington Conference Center in Baltimore. Over 125 CBH members, partners, speakers and vendors from across the state joined us for a full day of learning from peers and national best practives.
Members of the Community Behavioral Health Association of Maryland also become full members of the National Council for Behavioral Health and eligible for membership discounts.
CBH offers significant discounts on conference registration costs for the National Council's annual conference. Registration opens in September. Contact us for your membership discount code - last year CBH members saved over $20,000 through these discounts!
Join members of the Community Behavioral Health Association of Maryland and the Behavioral Health Coalition for a rally and march in Annapolis. Educating your legislators about the importance of behavioral health is important as this year's election has resulted in broad turnover.
Sheppard Pratt Health System is the largest private, non-profit provider of mental health, substance use, special education, developmental disability, and social services in the country. As a nationwide resource, we provide more than 160 programs across a comprehensive continuum of care. Since 1853, we have been innovating the field through research and best practice implementation, identifying new and effective ways to treat and improve the quality of mental health care on a global level. Sheppard Pratt has been consistently ranked as a top national psychiatric hospital by U.S. News & World Report for nearly 30 years.
Neurocrine Biosciences, a San Diego based biopharmaceutical company, is focused on developing treatments for neurological and endocrine related disorders. The company discovered, developed and markets INGREZZA® (valbenazine) capsules, the first FDA-approved treatment for adults with tardive dyskinesia, an involuntary movement disorder. For more information and the latest updates from Neurocrine Biosciences, please visit www.neurocrine.com.
Terrapin Pharmacy improves the lives of individuals suffering from complex physical and mental disorders who require multiple medications by simplifying the medication management process for patients and healthcare providers alike. We have spent the last decade continually rethinking pharmacy services and medication management in order to introduce new processes and innovations that help people overcome the barriers to medication adherence, thereby improving outcomes and reducing costs. Terrapin is dedicated to ensuring that our patients receive the right medications in the right dosages at the right times—medication adherence is our mission.